Scott P. Webster

2.7k total citations
65 papers, 1.9k citations indexed

About

Scott P. Webster is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Behavioral Neuroscience. According to data from OpenAlex, Scott P. Webster has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Molecular Biology and 15 papers in Behavioral Neuroscience. Recurrent topics in Scott P. Webster's work include Hormonal Regulation and Hypertension (31 papers), Stress Responses and Cortisol (15 papers) and Tryptophan and brain disorders (10 papers). Scott P. Webster is often cited by papers focused on Hormonal Regulation and Hypertension (31 papers), Stress Responses and Cortisol (15 papers) and Tryptophan and brain disorders (10 papers). Scott P. Webster collaborates with scholars based in United Kingdom, United States and Mexico. Scott P. Webster's co-authors include Brian R. Walker, Margaret Binnie, Dominic J. Campopiano, Robert L. Baxter, Jonathan R. Seckl, Samuel Estrada‐Soto, Gabriel Navarrete‐Vázquez, Rolffy Ortíz‐Andrade, Lindsay Sawyer and Dmitry Alexeev and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Scott P. Webster

63 papers receiving 1.8k citations

Peers

Countries citing papers authored by Scott P. Webster

Since Specialization

Citations

This map shows the geographic impact of Scott P. Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott P. Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott P. Webster more than expected).

Fields of papers citing papers by Scott P. Webster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott P. Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott P. Webster. The network helps show where Scott P. Webster may publish in the future.

Co-authorship network of co-authors of Scott P. Webster

This figure shows the co-authorship network connecting the top 25 collaborators of Scott P. Webster. A scholar is included among the top collaborators of Scott P. Webster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott P. Webster. Scott P. Webster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Optimization of Cyclophilin B-Targeted Tri-vector Inhibitors for Novel MASH Treatments	Journal of Medicinal Chemistry	John Robinson, Luchuo Engelbert Bain et al.	1
2	Small Interfering RNA Therapy Targeting the Long Noncoding RNA SMILR for Therapeutic Intervention in Coronary Artery Bypass Graft Failure	JACC Basic to Translational Science	Simon Brown, A. Malinowska et al.	0
3	Memory deficits in a juvenile rat model of type 1 diabetes are due to excess 11β-HSD1 activity, which is upregulated by high glucose concentrations rather than insulin deficiency	Diabetologia	Julie Brossaud, Clémentine Bosch‐Bouju et al.	2
4	Contribution of local regeneration of glucocorticoids to tissue steroid pools	Journal of Endocrinology	Shazia Khan, Dawn E. W. Livingstone et al.	1
5	5α‐Tetrahydrocorticosterone: A topical anti‐inflammatory glucocorticoid with an improved therapeutic index in a murine model of dermatitis	British Journal of Pharmacology	Dawn E. W. Livingstone, Karen Sooy et al.	3
6	Kynurenine monooxygenase regulates inflammation during critical illness and recovery in experimental acute pancreatitis	Cell Reports	Xiaozhong Zheng, Lucile Neyton et al.	9
7	11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis	PLoS ONE	Morwenna Muir, John C. Dawson et al.	1
8	A Novel Robotic Endoscopic Device Used for Operative Hysteroscopy	Journal of Minimally Invasive Gynecology	Richard J. Hendrick, Neal P. Dillon et al.	6
9	Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury	Experimental & Molecular Medicine	Xiaozhong Zheng, Ailiang Zhang et al.	43
10	Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion	Scientific Reports	Akihiro Kitamura, Yasmina Manso et al.	37
11	Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase	Nature Communications	Jonathan P. Hutchinson, Paul Rowland et al.	37
12	Detecting drug-target binding in cells using fluorescence-activated cell sorting coupled with mass spectrometry analysis	Methods and Applications in Fluorescence	Scott P. Webster, John P. Iredale et al.	6
13	Searching for novel applications of the benzohomoadamantane scaffold in medicinal chemistry: Synthesis of novel 11β-HSD1 inhibitors	Bioorganic & Medicinal Chemistry	Andrew McBride, Margaret Binnie et al.	4
14	A Magnetic Bead–Based Ligand Binding Assay to Facilitate Human Kynurenine 3-Monooxygenase Drug Discovery	SLAS DISCOVERY	Damian J. Mole, Natalie Homer et al.	8
15	Î²-Cell-Specific Glucocorticoid Reactivation Attenuates Inflammatory Î²-Cell Destruction	Frontiers in Endocrinology	Xiaoxia Liu, Sophie Turban et al.	8
16	Optimal Elevation of β-Cell 11β-Hydroxysteroid Dehydrogenase Type 1 Is a Compensatory Mechanism That Prevents High-Fat Diet–Induced β-Cell Failure	Diabetes	Sophie Turban, Xiaoxia Liu et al.	23
17	Modulation of 11β-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles	Bioorganic & Medicinal Chemistry Letters	Scott P. Webster, Margaret Binnie et al.	22
18	A comparative study of flavonoid analogues on streptozotocin–nicotinamide induced diabetic rats: Quercetin as a potential antidiabetic agent acting via 11β-Hydroxysteroid dehydrogenase type 1 inhibition	European Journal of Medicinal Chemistry	Mariana Torres‐Piedra, Rolffy Ortíz‐Andrade et al.	110
19	The mechanism of 7,8-diaminopelargonate synthase; the role of S-adenosylmethionine as the amino donor	Organic & Biomolecular Chemistry	Rachel Breen, Dominic J. Campopiano et al.	15
20	The crystal structure of 8-amino-7-oxononanoate synthase: a bacterial PLP-dependent, acyl-CoA-condensing enzyme 1 1Edited by R. Huber	Journal of Molecular Biology	Dmitry Alexeev, Marina Alexeeva et al.	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact